LifeVantage Corp.
(NASDAQ : LFVN)

( )
LFVN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-0.05%169.012.9%$366.95m
ZTSZoetis, Inc. Class A
-1.52%126.521.9%$222.59m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-2.32%6.742.0%$93.24m
MYLMylan N.V.
-2.01%18.523.2%$89.93m
TXMDTherapeuticsMD, Inc.
2.21%3.9324.9%$12.86m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
0.08%37.372.0%$5.85m
TAROTaro Pharmaceutical Industries Ltd.
-2.42%74.246.5%$3.24m
LFVNLifeVantage Corporation
1.57%14.253.3%$1.61m
ABEOAbeona Therapeutics, Inc.
-3.13%2.177.6%$1.33m
KINKindred Biosciences, Inc.
7.04%6.990.3%$0.74m
JAGXJaguar Animal Health, Inc.
-1.99%0.699.8%$0.71m
CPHIChina Pharma Holdings, Inc.
-5.04%0.250.1%$0.02m

Company Profile

LifeVantage Corp. engages in the identification, research, development, and distribution of advanced nutraceutical dietary supplements and personal care products. It operates through the Americas Region; and Asia/Pacific and Europe Region georaphical segments. The firm's products include Protandim, LifeVantage® Omega+ and ProBio, TrueScience, and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.